بدائل البحث:
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
non decrease » nn decrease (توسيع البحث), point decrease (توسيع البحث), note decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
non decrease » nn decrease (توسيع البحث), point decrease (توسيع البحث), note decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
521
Effect of Bcl-xL on proteins involved in the apoptotic pathway of MDCK cells.
منشور في 2024الموضوعات: -
522
-
523
Differences in growth, metabolism and migration of BY-02 cells compared with WT cells.
منشور في 2024الموضوعات: -
524
-
525
-
526
-
527
-
528
-
529
-
530
-
531
A summary of the included study characteristics.
منشور في 2025"…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …"
-
532
-
533
-
534
-
535
-
536
Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia...
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
537
General information of patient who diagnosis insomnia disorder (N = 518,119).
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
538
Treatment at first diagnosis of insomnia disorder (%).
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
539
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
منشور في 2025"…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…"
-
540
Akt3 null animals have reduced Aurora B expression and proliferation and increased apoptosis.
منشور في 2025الموضوعات: